At what enterprise value was MEDICAL-SURGICAL SOLUTIONS acquired in 2026?

During the acquisition of MEDICAL-SURGICAL SOLUTIONS by APOLLO GLOBAL MANAGEMENT in 2026, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 3b - 100b USD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.8x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of MEDICAL-SURGICAL SOLUTIONS when it was acquired by APOLLO GLOBAL MANAGEMENT?

The estimated EV/EBITDA multiple for MEDICAL-SURGICAL SOLUTIONS is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.8x. Join our community for free to access full valuation data and industry trends.

What was the revenue of MEDICAL-SURGICAL SOLUTIONS at the time of the deal?

The revenue of MEDICAL-SURGICAL SOLUTIONS at the time of the deal is estimated to be in the range of 5b - 100b USD. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of MEDICAL-SURGICAL SOLUTIONS during the acquisition?

MEDICAL-SURGICAL SOLUTIONS's EBITDA is estimated to be in the range of 750M - 1.3b USD. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the MEDICAL-SURGICAL SOLUTIONS acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the MEDICAL-SURGICAL SOLUTIONS deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.mckesson.com/about-us/newsroom/press-releases/2026/mckesson-signs-agreement-with-apollo-funds-for-strategic-minority-interest-in-medical-surgical-solutions/

← DATABASE

Home Database Healthcare & PharmaMEDICAL-SURGICAL SOLUTIONS

04/2026

MEDICAL-SURGICAL SOLUTIONS acquired by APOLLO GLOBAL MANAGEMENT

UNITED STATES Healthcare Services / Hospital Logistics EV 3b - 100b USD

Context

McKesson Corporation has finalized a definitive agreement to sell a minority ownership interest (13%) in its Medical-Surgical Solutions (MMS) business to funds managed by affiliates of Apollo. The strategic rationale for this transaction centers on a "separation-validation" play, merging the target's industry-leading technical operational depth in healthcare distribution with the acquirer's extensive expertise in supporting complex corporate carve-outs. This structural alignment provides the organization with the strategic and financial flexibility required to pursue its definitive separation strategy in preparation for a planned initial public offering. This operation allows the group to execute a definitive structural transition toward operating as a standalone company while maintaining a well-capitalized balance sheet. By incorporating the sponsor's strategic discipline and experience in public market transactions, the organization is now positioned to optimize its governance and operational platforms.

MEDICAL-SURGICAL SOLUTIONS, which reported an EBITDA margin of LOGIN in 2025, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.8x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

Medical-Surgical Solutions, MSS, operates as a comprehensive distributor of medical-surgical supplies, offering a specialized portfolio of over 300,000 products including high-precision surgical instruments, exam room diagnostic equipment, and advanced wound care solutions. Its business model integrates the distribution of consumables (such as personal protective equipment (PPE), incontinence products, and clinical laboratory supplies) with sophisticated technical services. These services encompass proprietary inventory management software, supply chain analytics, and clinical consulting designed to optimize the operational efficiency of non-acute facilities. Strategically, the firm focuses on the deployment of point-of-care testing technologies and pharmaceutical distribution tailored for ambulatory surgery centers, physician offices, and home healthcare environments. By providing both the physical hardware and the digital data-driven infrastructure for procurement, the entity facilitates the structural efficiency of localized clinical care.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2025

2024

Similar deals in Healthcare & Pharma

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
03/2026	RADNET	GLEAMER	FRANCE	Healthcare Services	RadNet acquired Gleamer in an all-cash transaction to integrate its automated diagnostic and reporting solutions into the DeepHealth platform. The acquisition aims to create the world's largest provider of clinical radiology AI solutions by combining RadNet's massive US imaging volume with Gleamer's advanced multi-modality software
03/2026	THERMO FISHER SCIENTIFIC	CLARIO HOLDINGS	UNITED STATES	Healthcare Services	Thermo Fisher Scientific has finalized the acquisition of Clario Holdings, Inc. from a prominent shareholder consortium led by Astorg, Nordic Capital, Novo Holdings, and Cinven. The strategic rationale for this transaction centers on the deep integration of the target's industry-leading endpoint data platform into the group's Laboratory Products and Biopharma Services segment
01/2026	SAGARD	QUIPMENT	FRANCE	Healthcare Services	Sagard NewGen acquired a significant minority stake in Quipment, fifteen years after its inception. The deal aims to accelerate Quipment's international expansion, particularly in the US and Asia, and to support its digital transformation
01/2026	ANTIN INFRASTRUCTURE	EMSERE	NETHERLANDS	Healthcare Services	Antin Infrastructure Partners, executing through its Mid Cap Fund I, has entered into a definitive agreement with Dutch family office and investment platform Gryphion to acquire 100% of Emsere. The transaction, which represents the eighth investment completed by Antin's dedicated mid-cap vehicle, is scheduled to close in the first quarter of 2026
01/2026	PERMIRA	CARNE GROUP	IRELAND	Healthcare Services	Permira has reached an agreement to acquire a significant minority stake in Carne Group. The transaction facilitates the complete exit of Vitruvian Partners (who invested in 2021) and other minority shareholders
01/2026	TPG	OPTUM UK	UNITED KINGDOM	Healthcare Services	TPG is in advanced negotiations to acquire Optum UK from UnitedHealth Group. This transaction follows UnitedHealth’s relatively short ownership of the asset, which it acquired in 2023 after an intensive regulatory review by the UK Competition and Markets Authority
11/2025	EURAZEO	EXCELYA	FRANCE	Healthcare Services	The management team of Excelya selected Eurazeo to invest as a minority partner with a ticket composed of a mix of equity (capped at 20%) and quasi-equity instruments, alongside a senior debt package. The transaction facilitated a partial liquidity event for the co-founding partner, who remains a minority shareholder, while providing the company with substantial firepower to pursue further international acquisitions
11/2025	ASKER HEALTHCARE GROUP	FINMED GROUP	FRANCE	Healthcare Services	Asker Healthcare Group has signed a definitive agreement to acquire 80% of the shares in Finmed Group, marking its strategic entry into the French healthcare market. This transaction serves as a platform acquisition, providing the Swedish-based group with a robust foundation to expand its presence in one of Europe's largest medical device markets
10/2025	EVOLEM	APPERTON	FRANCE	Healthcare Services	A French healthcare player specializing in the sterilization of reusable medical equipment has restructured its capital through a secondary MBO. Operating as a mission-critical infrastructure partner within the healthcare sector, the company commands high barriers to entry rooted in stringent clinical regulations and non-discretionary hospital decontamination mandates
05/2025	FIVE ARROWS	HUBLO	FRANCE	Healthcare Services	Hublo enters a new phase of its development by welcoming Five Arrows as its new lead shareholder. This transaction marks a transition from Venture Capital to Private Equity (Primary LBO). The entry of Five Arrows aims to provide Hublo with the strategic and financial resources to consolidate its leadership in France and accelerate its expansion in Europe, particularly in Germany and Northern Europe

REFERENCES

Valuation range: EV 3b - 100b USD

Revenue range: 5b - 100b USD

EBITDA range: 750M - 1.3b USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of MEDICAL-SURGICAL SOLUTIONS by APOLLO GLOBAL MANAGEMENT are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Acquirer: apollo global management